Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography, and the nuclear imaging modalities of PET and SPECT.

Medicare opts not to make CT radiation-related quality measure mandatory in 2027
The measure evaluates the proportion of scans that exceed certain thresholds for image noise or radiation dose across 18 categories.
Emphysema on baseline lung cancer CT a sign of future mortality risk
“Lung cancer screening shouldn’t just be looking for nodules. That’s a small part of what we see on the CT scan.”
Key trends in nuclear cardiology take center stage at ASNC 2025
Wael Jaber, MD, chair of the 2025 American Society of Nuclear Cardiology annual meeting, shared some key takeaways from the conference. “This is no longer just about imaging for coronary disease," he explained. "Nuclear cardiology now helps guide therapy across a wide range of conditions."
Lantheus misled investors about blockbuster imaging agent, class action lawsuit claims
Plaintiff attorneys claim the Massachusetts-based company shattered the competitive position of Pylarify, a PET imaging agent for prostate cancer.
GE HealthCare to acquire Alzheimer’s imaging AI firm Icometrix
Founded in 2011 and based in Belgium, the AI firm offers the first software for automating brain assessments needed to administer disease therapies from Biogen and Eli Lilly.

Metabolic PET imaging provides clues to developing Huntington’s disease

A functional neural network is under investigation as a major player in the progression of Huntington’s disease. Metabolic imaging of this region could serve as a tool for future treatments, according to a study published online Aug. 29 in the Journal of Clinical Investigation.

Chasing the lightning: Molecular epilepsy imaging with PET and SPECT

Recent studies have indicated that epilepsy may be more comprehensively characterized with the help of PET and SPECT, and these modalities could benefit the 1-2 percent of the U.S. population with the neurological disorder, according to a review published online Aug 22 in the Journal of Nuclear Medicine.

Estrogen receptor PET imaging detects early stage breast cancer, with limitations

Early-stage breast cancer lesions can be detected with F-18 FES PET, but success depends on tumor size and level of disease, according to a study published online Aug. 22 in the Journal of Nuclear Medicine.

Radical Radiopharmaceuticals: Molecular Imaging Agents Find Their Niche

Multiple radiopharmaceuticals in the development pipeline are showing real promise in the realms of oncology, neurology and cardiology.

PET on a Leash: Reimbursement Developments and Challenges

The operative phrase for PET reimbursement circa 2013 may be “cautiously optimistic.”

Radiation Exposure: Connecting the Dots

The right dose to the right patient at the right time is the mantra. But tracking dose is gaining in popularity among physicians and patients.

PEM: An Additional Arrow In the Breast Imaging Quiver

Many physicians and patients cast staging breast MRI as an imperfect exam. From the physician’s perspective, the exam generates thousands of difficult-to-interpret images. False-positive findings are not uncommon.

Cancer Care Informatics: Challenges In Nuclear Medicine

Multiple radiopharmaceuticals in the development pipeline are showing real promise in the realms of oncology, neurology and cardiology. 

Medical Imaging

Medicare opts not to make CT radiation-related quality measure mandatory in 2027

Emphysema on baseline lung cancer CT a sign of future mortality risk

Key trends in nuclear cardiology take center stage at ASNC 2025

Lantheus misled investors about blockbuster imaging agent, class action lawsuit claims

GE HealthCare to acquire Alzheimer’s imaging AI firm Icometrix